Losartan versus olmesartan in patients with essential hypertension and concentric left ventricular hypertrophy

被引:0
|
作者
Picca, M. [1 ]
Agozzino, F. [1 ]
Pelosi, G. C. [1 ]
机构
[1] Fatebenefratelli & Oftalm POMM, Div Internal Med AO, Milan, Italy
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:S24 / S24
页数:1
相关论文
共 50 条
  • [1] Influence of losartan on left ventricular hypertrophy and function in patients with essential hypertension
    Picca, M
    Agozzino, F
    Pelosi, GC
    CARDIOVASCULAR PHARMACOTHERAPY, 2000, : 389 - 393
  • [2] Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy
    Dahlof, B
    Zanchetti, A
    Diez, J
    Nicholls, MG
    Yu, CM
    Barrios, V
    Aurup, P
    Smith, RD
    Johansson, M
    JOURNAL OF HYPERTENSION, 2002, 20 (09) : 1855 - 1864
  • [3] Effects of losartan and valsartan on left ventricular hypertrophy and function in essential hypertension
    Picca, M
    Agozzino, F
    Pelosi, G
    ADVANCES IN THERAPY, 2004, 21 (02) : 76 - 86
  • [4] Effects of losartan and valsartan on left ventricular hypertrophy and function in essential hypertension
    Maurizio Picca
    Francesco Agozzino
    Giancarlo Pelosi
    Advances in Therapy, 2004, 21 : 76 - 86
  • [5] Losartan for LIFE in hypertension with left ventricular hypertrophy?
    Doggrell, SA
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (01) : 115 - 118
  • [6] Omapatrilat versus losartan in hypertensive patients with left ventricular hypertrophy
    Dahlof, B
    Agabiti-Rosei, E
    Zaliunas, R
    Moisejev, V
    Adamus, J
    Ruilope, L
    Keidar, S
    Levy, E
    JOURNAL OF HYPERTENSION, 2000, 18 : S42 - S42
  • [7] Soluble ST2 Is a Biomarker Associated With Left Ventricular Hypertrophy and Concentric Hypertrophy in Patients With Essential Hypertension
    Wang, Xia
    Han, Shu-Jie
    Wang, Xiao-Li
    Xu, Yun-Feng
    Wang, Hui-Cheng
    Peng, Jiang-Yang
    Pan, Guang-Ming
    Chen, Ya-Hui
    Wang, Chuangchang
    AMERICAN JOURNAL OF HYPERTENSION, 2024, 37 (12) : 987 - 994
  • [8] Left Ventricular Hypertrophy and Microalbuminuria in Patients With Essential Hypertension
    Monfared, Ali
    Salari, Arsalan
    Mirbolok, Fardin
    Momeni, Maryam
    Shafighnia, Shora
    Shakiba, Maryam
    Shikholeslami, Amir
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2013, 7 (03) : 192 - 197
  • [9] Regression of left ventricular hypertrophy with losartan potassium therapy in patients with hypertension
    Acartürk, E
    Demir, M
    Demircan, S
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (12): : 819 - 825
  • [10] Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy
    Fyhrquist, F
    Dahlöf, B
    Devereux, RB
    Kjeldsen, SE
    Julius, S
    Beevers, G
    de Faire, U
    Ibsen, H
    Kristianson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Hille, DA
    Lyle, PA
    Edelman, JM
    Snapinn, SM
    Wedel, H
    HYPERTENSION, 2005, 45 (04) : 580 - 585